# Ceftobiprole in Hospital Acquired Pneumonia

> **NCT00210964** · PHASE3 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 781 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** ceftobiprole plus placebo
- **DRUG:** linezolid plus ceftazidime

## Key facts

- **NCT ID:** NCT00210964
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 781 (ACTUAL)
- **Last updated:** 2012-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210964, "Ceftobiprole in Hospital Acquired Pneumonia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00210964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*